Medicover Stock

Medicover EBIT

The EBIT of Medicover (MCOV B.ST) as of Aug 9, 2026 is 155.70 M EUR. In the previous year, EBIT was 89.60 M EUR — a change of 73.77% (higher).

EBIT

155.70 MEUR

YoY

73.77%

Last updated:

In 2026, Medicover's EBIT was 155.70 M EUR, a 73.77% increase from the 89.60 M EUR EBIT recorded in the previous year.

The Medicover EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2022
69.00 base
Jan 1, 2023
61.90 base
Jan 1, 2024
89.60 base
Jan 1, 2025
155.70 base
Jan 1, 2026 (e)
198.95 base
Jan 1, 2027 (e)
251.27 base
Jan 1, 2028 (e)
297.76 base
Jan 1, 2029 (e)
355.15 base
YEAREBIT (M EUR)
2029 est 355.15
2028 est 297.76
2027 est 251.27
2026 est 198.95
2025 155.70
2024 89.60
2023 61.90
2022 69.00
2021 159.40
2020 66.50
2019 47.30
2018 33.70
2017 28.80
2016 21.10
2015 21.50
Access this data via the Eulerpool API

Medicover Revenue

Medicover Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.51 B EUR
69.00 M EUR
12.10 M EUR
Jan 1, 2023
1.75 B EUR
61.90 M EUR
17.60 M EUR
Jan 1, 2024
2.09 B EUR
89.60 M EUR
16.70 M EUR
Jan 1, 2025
2.38 B EUR
155.70 M EUR
77.50 M EUR
Jan 1, 2026 (e)
2.72 B EUR
198.95 M EUR
109.79 M EUR
Jan 1, 2027 (e)
3.04 B EUR
251.27 M EUR
147.91 M EUR
Jan 1, 2028 (e)
3.36 B EUR
297.76 M EUR
174.19 M EUR
Jan 1, 2029 (e)
3.73 B EUR
355.15 M EUR
170.76 M EUR

Medicover Margins

Medicover stock margins

The Medicover margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicover. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicover.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
22.54 %
4.57 %
0.80 %
Jan 1, 2023
20.58 %
3.54 %
1.01 %
Jan 1, 2024
21.43 %
4.28 %
0.80 %
Jan 1, 2025
23.16 %
6.55 %
3.26 %
Jan 1, 2026 (e)
23.16 %
7.31 %
4.03 %
Jan 1, 2027 (e)
23.16 %
8.27 %
4.87 %
Jan 1, 2028 (e)
23.16 %
8.86 %
5.19 %
Jan 1, 2029 (e)
23.16 %
9.52 %
4.58 %

Medicover Stock analysis

What does Medicover do? Medicover AB is a leading healthcare company in Europe with its headquarters in Stockholm, Sweden. The company was founded in 1995 by Fredrik Rågmark with the aim of providing high-quality medical care for patients. Medicover's business model is based on an integrated chain of healthcare services. This includes doctor's offices, specialists, diagnostic centers, hospitals, laboratories, health centers, and nursing services. The company operates in Poland, Romania, Hungary, Germany, Ukraine, and Belarus, and offers a wide range of healthcare services. The main sectors of Medicover include healthcare services for individuals and businesses, as well as the use of cutting-edge technologies and data analysis to improve patient care. The company offers a variety of services in the areas of prevention, diagnosis, and therapy, including laboratory tests, imaging, health checks, medical advice, and treatment of acute and chronic diseases. In the field of corporate services, Medicover offers occupational medicine, corporate health management, as well as health programs and training for employees of companies. This helps promote the health and well-being of employees while achieving higher productivity and efficiency. Products offered by Medicover include insurance services, hospital services, travel medicine, vaccinations, child care, and family planning. The company also offers specialized programs for patients with chronic diseases such as diabetes, hypertension, and cardiovascular diseases. An important component of Medicover's business model is the use of data analysis and technology to improve patient care. The company leverages the latest innovations in medical technology such as telemedicine, electronic health records, and mobile applications to enable faster and more effective access to healthcare. With a strong focus on quality and customer satisfaction, Medicover has become one of the leading healthcare companies in Europe. The company employs over 25,000 employees and serves over 6 million patients per year. In summary, Medicover is an innovative and integrated company in the healthcare industry, specializing in providing high-quality healthcare services and utilizing advanced technologies and data analysis to improve patient care. Medicover is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Medicover's EBIT

Medicover's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Medicover's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Medicover's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Medicover’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Medicover stock

EBIT of Medicover is 155.70 M EUR in 2026.

EBIT of Medicover changed from 89.60 M EUR to 155.70 M EUR, representing a 73.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Medicover since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Medicover historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Medicover

All Key Metrics — Medicover